Astellas.com - SEO Checker

¡Registrarme gratis! Exportar PDF
Visión general del análisis SEO
Metadatos
75% 
Calidad de la página
79% 
Estructura
79% 
Enlazado
85% 
Servidor
95% 
Factores externos
100% 
Puntuación SEO
Tiempo de carga
1,86 s
Tamaño HTML
84,90 kB
Palabras
1056
Medios
18
Cantidad de enlaces
203 internos / 4 externos

Lista de tareas pendientes para mejorar tu SEO

Metadatos

Título
(Extremadamente importante)
Astellas Home page | Astellas Pharma Inc.
La longitud del título es óptima (383 píxeles de una longitud máxima de 580 píxeles).
No se repite ninguna palabra en el título.
Meta descripción
(Extremadamente importante)
Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.
La meta descripción es demasiado larga: 1000 píxelesOptimizar la descripción.
Rastreabilidad
(Extremadamente importante)
No se detectan problemas para acceder al sitio web.
Redirección canónica
(Importante)
https://www.astellas.com/en
El enlace canónico especificado apunta a una URL diferente.
Idioma
(Poco importante)
Idioma reconocido automáticamente en el contenido: en
Idioma declarado en el código HTML: en
Ubicación geográfica del servidor: Estados Unidos de América
El idioma ha sido correctamente declarado en el código HTML: en.
Enlaces Alternate/Hreflang
(Poco importante)
No se identifica ningún error en los enlaces alternate/hreflang.
Otras Metaetiquetas
(Poco importante)
No se detecta ninguna metaetiqueta de paginación rel next en la página.
No se detecta ninguna metaetiqueta de paginación rel prev en la página.
Dominio
(Poco importante)
El dominio no es un subdominio.
La longitud del nombre del dominio es buena.
El dominio no contiene caracteres especiales.
URL de la página
(Poco importante)
No se detecta ningún parámetro dinámico en la URL.
No se detecta ningún ID de sesión en la URL.
La URL no contiene demasiados subdirectorios.
Codificación de caracteres
(Poco importante)
La codificación de caracteres (UTF-8) ha sido declarada correctamente.
Doctype
(Deseable)
La etiqueta doctype HTML 5 está configurada correctamente.
La declaración del doctype se ubica al inicio del código HTML.
Favicon
(Deseable)
El favicon está enlazado correctamente.

Metaetiquetas

NombreValor
descriptionAstellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.
thumbnailhttps://www.astellas.com/en/jp/sites/all/themes/astellas/logo.svg
GeneratorDrupal 10 (https://www.drupal.org)
MobileOptimizedwidth
HandheldFriendlytrue
viewportwidth=device-width, initial-scale=1.0
langen
twitter:cardsummary_large_image
twitter:titleTOP
twitter:imagehttps://www.astellas.com/en/sites/all/themes/astellas/astellas_logo_1200-630.jpg
og:titleAstellas Home page | Astellas Pharma Inc.
og:descriptionAstellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.
og:imagehttps://www.astellas.com/en/sites/all/themes/astellas/astellas_logo_1200-630.jpg
charsetutf-8

¡Analiza ya gratis hasta 1.000 páginas de astellas.com!

Registrarme Gratis
Puedes usar la suscripción Básica por tiempo ilimitado.

Calidad de la página

Contenido
(Extremadamente importante)
Algunas palabras del título no se repiten en el cuerpo del texto.
El número total de palabras en la página es bueno: 1056 palabras.
Un 24% del contenido está constituido por palabras vacías.
La página contiene un listado, lo que indica una buena estructuración del contenido.
Se han encontrado 11 párrafos en esta página.
No se detecta ningún placeholder de texto ni imagen.
No se detecta contenido duplicado.
La cantidad media de palabras por frase es buena: 18.5 palabras.
Frames
(Extremadamente importante)
Esta página no utiliza ningún frameset.
Optimización para móviles
(Poco importante)
No se ha especificado ningún icono de Apple Touch.
El valor de la etiqueta viewport es correcto: (width=device-width, initial-scale=1.0).
Etiquetas Bold y Strong
(Poco importante)
El uso de etiquetas de negritas en esta página es óptimo. Te recomendamos emplear hasta 21 etiquetas de negritas en una página.
Optimización de imágenes
(Poco importante)
La descripción del atributo ALT se utiliza correctamente en todas las imágenes rastreadas.
Redes Sociales
(Deseable)
Esta página apenas ofrece posibilidades de compartir el contenido en redes sociales. Con la integración de widgets puedes conseguir que tus contenidos se popularicen en redes.
Etiquetas markup adicionales
(Deseable)
No se detecta ninguna etiqueta markup (de Schema.org) adicional.
HTTPS
(Poco importante)
El sitio utiliza HTTPS para transferir datos de forma segura.
Todos los archivos incluidos se transfieren a través de HTTPS.

Lista de medios

URLAtributo ALTTítulo
/themes/custom/astellas_v2/logo.svgAstellas Pharma Inc.Astellas Pharma Inc.
/sites/all/themes/astellas/logo.svglogo
...er_Integrated-Report-2024_1920x523px.pngIntegrated Report 2024
...der_Integrated-Report-2024_960x540px.pngIntegrated Report 2024
...image/2024-10/Story_960-540px_topics.jpgLeading the Charge in Oncology
..._banner_image/2024-10/600_300_topics.jpgFinancial Results for Q1/FY2024
...er_image/2023-05/From the CEO_600300.pngFrom the CEO
...lated_banner_image/2022-10/top_about.pngAbout us
...ted_banner_image/2022-10/top_r-and-d.pngR & D Strategy
...ner_image/2022-10/top_sustainability.pngAstellas and Sustainability
...mage/2022-10/top_partnering_20221017.pngPartnering with Astellas
...mage/2022-10/top_partnering_20221017.pngPartnering with Astellas
...sub_menu_image/2022-10/top_investors.pngInvestor Relations
.../sub_menu_image/2022-10/top_linkedin.pngLinkedIn
...ll/themes/astellas/images/logo_white.svgfooter logo
...all/themes/astellas/images/solgan_en.svgfooter solgan
...les/bxbito15231/files/linkedin_small.pngLinkedin Logo
...les/bxbito15231/files/youtube_footer.pngYoutube Logo

Estructura de la página

Encabezado H1
(Extremadamente importante)
No se ha detectado ningún encabezado H1.
Encabezados
(Importante)
En la estructura de los encabezados H faltan uno o varios niveles.

Estructura de los encabezados

Jerarquía de encabezadosContenido
H2 Stakeholders menu
H2 Common header menu
H2 Integrated Report 2024
H2 Leading the Charge in Oncology
H2 Financial Results for Q1/FY2024
H2 From the CEO
H2 About us
H2 R & D Strategy
H2 Sustainability
H2 Partnering with Astellas
H2 Investor Relations
H2 Astellas Pharma’s official LinkedIn
H2 Modern Slavery Act 2015
H2 Contact for Potential Acquisition of Astellas’ R＆D programs.
H2 Bottom footer menu
Algunos textos ancla son demasiado largos.
Algunos textos ancla se repiten más de una vez en varios enlaces.
La cantidad de enlaces internos es adecuada.
Ningún enlace interno contiene parámetros dinámicos.
Hay 4 enlaces externos en esta página.

Enlaces detectados en esta página

EnlacePropiedadesTexto ancla
https://www.astellas.com/enIMG-ALT Astellas Pharma Inc.
https://www.astellas.com/en/aboutAbout
/en/investors/strategic-planCorporate Strategic Plan 2021 Corporate Strategic Plan 2021 (CSP2021) maps the next five years of our journey. Read More
/en/about/messageFrom the CEO
/en/about/philosophyPhilosophy
/en/about/charter-of-corporate...Astellas Charter of Corporate Conduct, Group Code of Conduct
/en/about/visionVISION
/en/about/corporate-informationAt a Glance
/en/about/subsidiaries-and-loc...Subsidiaries & Locations
/en/about/our-businessOur Business
/en/about/main-productsMain Products
/en/about/historyHistory
/en/about/managementManagement
/en/about/board-of-directorsBoard of Directors
/en/about/top-managementGlobal Management Structure
/en/about/governanceCorporate Governance Materials
/en/about/risk-managementRisk Management
/en/about/policies-and-positio...Policies & Position Statements
/en/about/ethics-complianceEthics & Compliance
/en/about/structure-to-promoteStructure to Promote Ethics and Compliance
/en/about/primary-areas-of-focusPrimary Areas of Focus
/en/about/elements-of-astellas...Elements of Astellas’ Global Ethics & Compliance Program
/en/about/enhancing-and-sustai...Enhancing and Sustaining an Ethical and Compliant Culture at Astellas
/en/about/astellas-compliance-...Astellas awarded Compliance Leader Verification™
/en/innovationInnovation
/en/innovationInnovation We pursue cutting-edge science to continuously provide innovative treatment options. Read More
/en/innovation/rd-strategyR＆D Strategy
/en/innovation/drug-researchDrug Research
/en/innovation/pipelineMajor Pipeline
/en/innovation/clinical-trialsClinical Trials
/en/innovation/investigator-sp...Investigator Sponsored Research
/en/innovation/grants-for-educ...Grants for Education and General Research
/en/innovation/grants-for-educ...Grants to HCOs to Support HCP Attendance at Congresses
/en/innovation/areas-of-interestAreas of Interest
/en/innovation/primary-focus-g...Genetic Regulation
/en/innovation/primary-focus-i...Immuno-Oncology
/en/innovation/primary-focus-b...Blindness & Regeneration
/en/innovation/primary-focus-t...Targeted Protein Degradation
/en/innovation/primary-focus-c...Immune Homeostasis
/en/innovation/exploratory-res...Bispecific Immune Cell Engager
/en/innovation/engineered-phag...Engineered Phage Therapy
/en/innovation/direct-reprogra...Direct Reprogramming
/en/innovation/innate-immune-r...Innate Immune Regulation
/en/innovation/circadian-rhyth...Circadian Rhythm Regulation
/en/innovation/cell-therapyCell Therapy
/en/innovation/digital-transfo...Digital Transformation
/en/innovation/dx-initiatives-...DX Initiatives Throughout the Value Chain
/en/innovation/data-informatio...Data, Information and Advanced Analytics
/en/innovation/rx-plusNew Healthcare Solutions Beyond Medicine (Rx+®)
/en/innovation/leading-programsLeading Programs
/en/innovation/investigational...Investigational Near-Infrared Fluorescence Imaging Agent
/en/innovation/clinically-rele...Clinically Relevant Holistic Solutions Mobile Healthcare Application
/en/innovation/new_digital_the...New Digital Solution for Heart Failure Patients on the Horizon
/en/innovation/open-innovationOpen Innovation in Drug Discovery Research
/en/innovation/open-innovation...Our Philosophy of Open Innovation
/en/innovation/open-innovation...SakuLab-Tsukuba
/en/innovation/open-innovation...TME iLab
/en/innovation/open-innovation...SakuLab-Cambridge MA
/en/partneringSubdominio Partnering
/en/investorsInvestors
/en/investorsInvestor Relations You can access to IR related information including IR Library, Financial Information, Corporate Strategic Plan. Read More
/en/investors/strategic-planCorporate Strategic Plan 2021
/en/investors/integrated-reportIntegrated Report
/en/investors/integrated-repor...Archives
/en/investors/astellas-esg-ini...Astellas’ ESG Initiatives
/en/investors/enhancementAction to Implement Management that is Conscious of Cost of Capital and Stock Price
/en/investors/financial-inform...Financial Information
/en/investors/ir-libraryIR Library
/en/investors/ir-library/busin...Business Results
/en/investors/ir-library/pipelineOverview of R&D Pipeline
/en/investors/ir-library/ir-me...IR Meetings
/en/investors/consolidated-fin...Consolidated Financial Statements and Footnotes
/en/about/governanceTexto duplicado Corporate Governance Materials
/en/investors/ir-calendarIR Calendar
/en/investors/stock-rating-inf...Stock & Rating Information
/en/investors/shareholders-mee...Shareholders Meeting
/en/investors/shareholder-returnShareholder Return
/en/investors/current-share-st...Current Share Status
/en/investors/chartChart
/en/investors/ratingsIssuer Rating
/en/investors/analyst-coverageAnalyst Coverage
/en/investors/cautionary-state...Cautionary Statement
/en/investors/individual-inves...Introducing Astellas to Individual Investors
/en/sustainabilitySustainability
/en/sustainability/sustainabil...Sustainability Direction We have set Med-term Priorities, Initiatives, and Our Commitments by FY2025 as for Two pillars and Environmental Sustainability. Rea...
/en/sustainability/our-approachMessage from CEO
/en/sustainability/sustainabil...Sustainability Approach
/en/sustainability/astellas-su...Sustainability Governance
/en/sustainability/materialityKey Issues and Materiality
/en/sustainability/sustainabil...Sustainability Direction
/en/sustainability/sdpisSustainability Direction Performance Indicators (SDPIs)
/en/sustainability/iso26000ISO26000
/en/sustainability/un-developm...Astellas’ SDG Initiatives
/en/sustainability/united-nati...United Nations Global Compact
/en/sustainability/stakeholder...Stakeholder Communications
/en/sustainability/awards-and-...Awards & Recognition
/en/sustainability/access-to-h...Access to Health
/en/sustainability/access-to-h...Access to Health of Astellas
/en/sustainability/access-to-m...Access to Medicines
/en/sustainability/initiatives...Initiatives in Tanzania
/en/sustainability/strengtheni...Healthcare Systems Strengthening
/en/sustainability/program-in-...Program in Mexico
/en/sustainability/program-in-...Program in Dominican Republic
/en/sustainability/program-in-...Program in Peru
/en/sustainability/program-in-...Program in Malaysia
/en/sustainability/development...Development for Schistosomiasis
/en/sustainability/research-ac...Research Activity on Malaria
/en/sustainability/research-ac...Research Activities on NTDs
/en/sustainability/astellas-he...Astellas Healthcare E-city
/en/sustainability/ghit-fundGHIT Fund
/en/sustainability/enrich-the-...Patient Support Activity
/en/sustainability/sustainable...Working together to bring “medical-eco” activities to drug discovery in Japan
/en/sustainability/cncCommitment to healthcare for local communities
/en/sustainability/project-com...Activities of "Project Commune" in FY 2023
/en/sustainability/project-com...Activities of "Project Commune" in FY 2024
/en/sustainability/advancement...Medical Science Advancement
/en/sustainability/astellas-gl...Astellas Global Health Foundation
/en/sustainability/access-to-m...Access to Medicine Index Report
/en/sustainability/environmentEnvironment
/en/sustainability/initiatives...Environment Initiatives
/en/sustainability/environment...EHS Management
/en/sustainability/status-of-o...ISO certification status of Astellas production sites
/en/sustainability/environment...Environmental Action Plan and Compliance
/en/sustainability/measures-to...Climate Change Measures
/en/sustainability/scope-3-emi...Scope 3 emissions (past 3 years)
/en/sustainability/TCFD-disclo...Disclosure based on TCFD
/en/sustainability/breakdown-o...Energy Consumption
/en/sustainability/preserving-...Sustainable Biodiversity
/en/sustainability/preserving-...Biodiversity and Astellas An Enlarged Version
/en/sustainability/the-biodive...The Biodiversity Burden Index and Revenue
/en/sustainability/initiatives...Resource Recycling
/en/sustainability/initiatives...Preventing Pollution
/en/sustainability/further-inf...Further information on PRTR system
/en/sustainability/environment...Environmental Impact of Products and Countermeasures
/en/sustainability/environment...Archive (EHS Report)
/en/sustainability/environment...Environmental Accounting
/en/sustainability/environment...Environment-related Investments and Expenses
/en/sustainability/reporting-c...Reporting coverage, methods
/en/sustainability/socialAstellas and Society
/en/sustainability/our-peopleOur People
/en/sustainability/hr-visionHR Vision, Talent and Organization Management
/en/sustainability/diversity-m...Engagement and Diversity, Equity & Inclusion
/en/sustainability/a-living-wageA living wage
/en/sustainability/occupationa...Occupational Health & Safety
/en/sustainability/promoting-h...Promoting Health Management
/en/sustainability/major-progr...Major Activities and Programs (Japan)
/en/sustainability/sustainabil...Sustainability in Business Practice
/en/sustainability/sustainable...Sustainable Procurement Initiatives
/en/sustainability/research-in...Research Initiatives
/en/sustainability/clinical-de...Clinical Development Initiatives
/en/sustainability/technologic...Technological Development and Production Initiatives
/en/sustainability/distributio...Distribution and Sales Initiatives
/en/sustainability/respect-for...Respect for Human Rights
/en/sustainability/community-e...Community Engagement
/en/sustainability/flyingstarFlying Star Fund
/en/sustainability/changing-to...Employee Contributions to the Local Community
/en/sustainability/governanceGovernance
/en/sustainability/esgESG Data
/en/sustainability/esg-environ...ESG Data Environment
/en/sustainability/esg-socialESG Data Social
/en/sustainability/esg-governanceESG Data Governance
/en/newsroomNews
/en/newsroomNews Room Check the latest news and our people's stories. Read More
https://www.astellas.com/en/newsALL News
/en/storiesOUR STORIES
/en/newsroom/media-libraryMedia Library
/en/partneringTexto duplicado Partnering
/en/partnering/partnershipWhy Partner with Astellas
/en/partnering/partnering-teamsPartnering Teams
/en/partnering/testimonies-fro...Testimonies from our Partners
/en/partnering/register-formRegistration Form
/en/careers-at-astellasCareers
/en/suppliersSuppliers
/en/contact-usContact Us
https://www.astellas.com/enIMPORTANT NOTICE
/en/worldwideWORLDWIDE
https://www.astellas.com/enGLOBAL
https://www.astellas.com/jp日本
https://www.astellas.com/Cancel
https://www.astellas.com/Nueva ventana Click here to leave this site.
/en/system/files/8ddc22a762/as...Subdominio Integrated Report 2024 Please check the latest Integrated Report. View more
/en/stories/leading_the_charge...Leading the Charge in Oncology Chief Medical Officer Tadaaki Taniguchi shares insights on how Astellas is advancing oncology with next-generation modalities....
IMG-ALT Leading the Charge in Oncology
/en/investors/ir-library/busin...Financial Results for Q1/FY2024 We announced our financial results for Q1/FY2024 on August 1st. Presentation material, video, and meeting script are availabl...
IMG-ALT Financial Results for Q1/FY2024
/en/about/messageFrom the CEO I will make every effort to navigate Astellas with speed and a sense of urgency that “our patients are waiting.” Read more
IMG-ALT From the CEO
/en/news/29471Oct 04, 2024General News Integrated Report 2024 is now available.
/en/news/29466Oct 02, 2024Stories Leading the Charge in Oncology: How Astellas is Redefining Cancer Treatment
/en/news/29451Sep 24, 2024Press Releases Japan’s Ministry of Health, Labour and Welfare Approves PADCEVTM (enfortumab vedotin) with KEYTRUDA® (pembrolizumab) for First-Lin...
https://www.astellas.com/en/newsEXPLORE ALL NEWS
https://www.astellas.com/en/aboutAbout us Astellas aims to stand on the forefront of healthcare change to turn innovative science into VALUE for patients. Read more
IMG-ALT About us
/en/innovation/rd-strategyR & D Strategy Astellas’ Focus Area approach supports our commitment to continuous innovation and the creation of innovative therapies that directly address ...
IMG-ALT R & D Strategy
/en/sustainabilitySustainability We are developing a sustainable society by leveraging Astellas’ strengths and capabilities. Read more
IMG-ALT Astellas and Sustainability
/en/partneringPartnering with Astellas We are actively seeking collaboration opportunities with external partners. Read More
/en/careers-at-astellasTexto duplicado Careers
/en/investorsInvestor Relations Read More
IMG-ALT Investor Relations
https://www.linkedin.com/compa...Externo Subdominio Astellas Pharma’s official LinkedIn We share the latest information and topics. Follow us
IMG-ALT LinkedIn
/en/sustainability/respect-for...Modern Slavery Act 2015
/en/contact-r-and-d-programsSubdominio Contact for Potential Acquisition of Astellas’ R＆D programs.
https://www.linkedin.com/compa...Nueva ventana Externo Subdominio IMG-ALT Linkedin Logo
https://www.youtube.com/user/a...Nueva ventana Externo Subdominio IMG-ALT Youtube Logo
/en/global-linkedin-community-...Global LinkedIn Community Guidelines
A-TITLE Global LinkedIn Community Guidelines
/en/sitemapSITE MAP
/en/privacy-noticePRIVACY NOTICE
/en/cookies-policyCOOKIES POLICY
/en/accessibilityACCESSIBILITY
/en/terms-of-useTERMS OF USE
/en/contact-usCONTACT US
https://www4.bcportal.jp/astel...Externo Subdominio DISASTER INFORMATION FOR EMPLOYEES

Configuración del servidor

Redirecciones HTTP
(Extremadamente importante)
Esta página redirige a "https://www.astellas.com/en/".
Cabecera HTTP
(Importante)
La cabecera X-Powered-by no se envía en la cabecera de la página.
Esta página utiliza GZip para la transmisión de datos comprimidos.
Rendimiento
(Poco importante)
Con 1,86 segundos, el tiempo de respuesta de la página es superior al límite recomendado de 0,4 segundos. Un tiempo de respuesta elevado ralentiza innecesariamente el rastreo de los buscadores y propicia una mala experiencia de uso.
El tamaño HTML de la página es adecuado: 85 kB.

Cabecera HTTP

NombreValor
dateSun, 06 Oct 2024 06:42:04 GMT
content-typetext/html; charset=UTF-8
expiresSun, 19 Nov 1978 05:00:00 GMT
cache-controlmax-age=3600, public
varyCookie
x-drupal-dynamic-cacheUNCACHEABLE
content-languageen
x-content-type-optionsnosniff
x-frame-optionsSAMEORIGIN
last-modifiedFri, 04 Oct 2024 07:53:11 GMT
x-generatorDrupal 10 (https://www.drupal.org)
content-security-policydefault-src https: 'self' wss:; script-src https: 'unsafe-inline' 'unsafe-eval' 'self'; object-src 'self' sw4503.swcms.net; style-src https: 'unsafe-inline' 'self'; img-src https: data: www.astellas.com lh6.googleusercontent.com www.sto.ch 'self'; media-src * blob:; frame-src 'self' vars.hotjar.com sw4503.swcms.net www.google.com consentcdn.cookiebot.com www.googletagmanager.com www.youtube-nocookie.com www.youtube.com asia.tools.euroland.com player.vimeo.com login.doccheck.com w.soundcloud.com dreambroker.com td.doubleclick.net online.flippingbook.com; child-src 'self' blob: vars.hotjar.com sw4503.swcms.net www.google.com consentcdn.cookiebot.com www.googletagmanager.com www.youtube-nocookie.com www.youtube.com asia.tools.euroland.com player.vimeo.com login.doccheck.com w.soundcloud.com dreambroker.com td.doubleclick.net; font-src https: 'self' data:; report-uri /report-csp-violation
x-xss-protection1; mode=block
strict-transport-securitymax-age=1000
referrer-policystrict-origin-when-cross-origin
x-drupal-cacheMISS
x-request-idv-b428ce16-8225-11ef-af7e-0bf873a3b563
x-ah-environment01live
age2638
viavarnish
x-cacheHIT
x-cache-hits355
cf-cache-statusDYNAMIC
servercloudflare
cf-ray8ce3ab524bd071d3-FRA
content-encodinggzip
statuscode200
http_versionHTTP/2

Factores externos

Wikipedia enlaza esta página en sus fuentes.
Esta página recibe enlaces de calidad de otros sitios web.
Esta página recibe backlinks de 459 dominios de referencia.
Esta página recibe un total de 4.064 backlinks.
Esta página recibe backlinks de 402 direcciones IP distintas.

Backlinks desde Wikipedia

Descubre más links en la función de búsqueda de Wikipedia

Robots.txt

#
# robots.txt
#
# This file is to prevent the crawling and indexing of certain parts
# of your site by web crawlers and spiders run by sites like Yahoo!
# and Google. By telling these "robots" where not to go on your site,
# you save bandwidth and server resources.
#
# This file will be ignored unless it is at the root of your host:
# Used:    http://example.com/robots.txt
# Ignored: http://example.com/site/robots.txt
#
# For more information about the robots.txt standard, see:
# http://www.robotstxt.org/robotstxt.html

User-agent: *
# CSS, JS, Images
Allow: /core/*.css$
Allow: /core/*.css?
Allow: /core/*.js$
Allow: /core/*.js?
Allow: /core/*.gif
Allow: /core/*.jpg
Allow: /core/*.jpeg
Allow: /core/*.png
Allow: /core/*.svg
Allow: /profiles/*.css$
Allow: /profiles/*.css?
Allow: /profiles/*.js$
Allow: /profiles/*.js?
Allow: /profiles/*.gif
Allow: /profiles/*.jpg
Allow: /profiles/*.jpeg
Allow: /profiles/*.png
Allow: /profiles/*.svg
# Directories
Disallow: /core/
Disallow: /profiles/
# Files
Disallow: /README.txt
Disallow: /web.config
Disallow: /sites/all/themes/astellas/js/astellas-popup.js
# Paths (clean URLs)
Disallow: /admin/
Disallow: /comment/reply/
Disallow: /filter/tips
Disallow: /node/add/
Disallow: /search/
Disallow: /user/register/
Disallow: /user/password/
Disallow: /user/login/
Disallow: /user/logout/
# Paths (no clean URLs)
Disallow: /index.php/admin/
Disallow: /index.php/comment/reply/
Disallow: /index.php/filter/tips
Disallow: /index.php/node/add/
Disallow: /index.php/search/
Disallow: /index.php/user/password/
Disallow: /index.php/user/register/
Disallow: /index.php/user/login/
Disallow: /index.php/user/logout/
# Disallow indexing of the entire SMPC backend
Disallow: /de/system/files/smpc/*
Disallow: /me/system/files/smpc/*
Disallow: /de/system/files/hcp/*
Disallow: /ch/system/files/hcp/*
Disallow: /ch/*/system/files/hcp/*
Disallow: /pl/system/files/privatefile/*
Disallow: /eu/system/files/c2p_astellas_sccs.0223_.pdf
Disallow: /system/files/astellas_sustainability_emailsignature_logo.jpg
Disallow: /system/files/astellas_sustainability_emailsignature_missionvision.jpg
Disallow: /me/system/files/pre-approved_global_congress_list_2023.pdf
Disallow: /br/system/files/mini-393186-xta-bra_xtandi_set_2023.pdf
Disallow: /en/system/files/privatefile/*
Disallow: /jp/system/files/privatefile/*
Disallow: /system/files/privatefile/*
Sitemap: https://www.astellas.com/sitemap.xml

Páginas similares

Snippet (vista previa de los resultados de búsqueda)

www.astellas.com
Astellas Home page | Astellas Pharma Inc.
Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.

Palabras clave más importantes

Se han encontrado las siguientes palabras clave. Comprueba si esta página está bien optimizada para cada palabra clave en concreto.

Palabra claveResultadoComprobar
Astellas77%Check
Astellas Pharma73%Check
Astellas Pharma Inc70%Check
Inc60%Check
Astellas Global57%Check
Health46%Check
Products46%Check
innovative46%Check
Japan46%Check
VISION46%Check
Mostrar más palabras clave

¡Analiza ya gratis hasta 1.000 páginas de astellas.com!

Registrarme Gratis
Puedes usar la suscripción Básica por tiempo ilimitado.

Política de cookies

Utilizamos cookies para el buen funcionamiento de nuestra web y con fines analíticos y publicitarios. Puedes activar o desactivar las cookies opcionales. Para más información consulta los siguientes enlaces.

Aviso legal | Privacidad y Cookies

Utilizamos estas cookies para que el sitio funcione correctamente

Con estas cookies podemos entender mejor cómo navegan las y los visitantes por nuestra web

Estas cookies nos ayudan a ofrecerte anuncios y promociones que se ajusten a tus intereses